Domingo Rodriguez

The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial

James T. Dalton, K. Gary Barnette, Casey E. Bohl et al. · Journal of Cachexia Sarcopenia and Muscle · 2011 · 386 citations · Full text

Healthy Elderly Men, Pharmacotherapy, Obesity +21

Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Matthew Smith, Ronald A. Morton, K. Gary Barnette et al. · The Journal of Urology · 2012 · 160 citations

Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

Matthew Smith, Ronald A. Morton, K. Gary Barnette et al. · The Journal of Urology · 2010 · 121 citations · Full text

Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis

K. Gary Barnette, Michael S. Gordon, Domingo Rodriguez et al. · NEJM Evidence · 2022 · 42 citations

A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor–targeting Agent

Mark C. Markowski, Ronald Tutrone, Christopher Pieczonka et al. · Clinical Cancer Research · 2022 · 33 citations · Full text